Language selection

Search

Details for: KETALAR

Company: ERFA CANADA 2012 INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
00224391KETALARKETAMINE (KETAMINE HYDROCHLORIDE)10 MG / MLSOLUTIONINTRAMUSCULAR
00224391KETALARKETAMINE (KETAMINE HYDROCHLORIDE)10 MG / MLSOLUTIONINTRAVENOUS
00224405KETALARKETAMINE (KETAMINE HYDROCHLORIDE)50 MG / MLSOLUTIONINTRAMUSCULAR
00224405KETALARKETAMINE (KETAMINE HYDROCHLORIDE)50 MG / MLSOLUTIONINTRAVENOUS
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Sedative and anesthetic drugs (DIPRIVAN [propofol], KETALAR [ketamine], SEVORANE [sevoflurane], SUPRANE [desflurane], FORANE/ISOFLURANE USP [isoflurane] - Assessing the potential risk of negative effects on the development of children's brains (neurodevelopmental disorders)
Summary Safety Review - Ketamine - Assessing the Potential Risk of Liver and Bile Duct Damage

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: